05 abril 2018

Malignant Pleural Mesothelioma (MPM) . Yondelis . ( Actualización ) .

Hoy también se ha sabido que :


****************************

Malignant Pleural Mesothelioma (MPM) . Yondelis . ( Actualización ) :

Resultado de imagen de malignant pleural mesotheliomaATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) (ATREUS) .

Sponsor : Mario Negri Institute for Pharmacological Research.

Collaborator : PharmaMar.

Information provided by (Responsible Party) : Mario Negri Institute for Pharmacological Research.

Study NCT02194231
on Date: March 27, 2018 (v5).

Study Identification
Unique Protocol IDn : IRFMN-MPM-6077


Brief Title: ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) (ATREUS).


Official Title: ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM).


Secondary IDs: 2011-006330-16 [EudraCT Number]

Study Status

Record Verification : March 2018
Overall Status : Recruiting
Study Start : July 2013.


Primary Completion : November 2018 [Anticipated].
Study Completion : November 2018 [Anticipated].